Cell And Gene Therapy Bioanalytical Testing Services Market To Reach $828.7 Million By 2030

May 2025 | Report Format: Electronic (PDF)

Cell And Gene Therapy Bioanalytical Testing Services Market Growth & Trends

The global cell and gene therapy bioanalytical testing services market size is expected to reach USD 828.7 million by 2030, registering a CAGR of 7.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing R&D activities related to cell and gene therapy, growth in investments by public organizations for cell and gene therapy research and high potential of gene and cell therapy in treating rare diseases are the key factors driving the growth of the market.

Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.

Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.

The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.


key Request a free sample copy or view report summary: Cell And Gene Therapy Bioanalytical Testing Services Market Market Report


Cell And Gene Therapy Bioanalytical Testing Services Market Report Highlights

  • The bioavailability & bioequivalence studies dominated with a market share of 35.44% in 2024 and are also expected to witness the fastest growth over the forecast period.

  • The non-clinical segment dominated the market in 2024. The stage of development segment has been further classified based on the product type, which includes gene therapy, gene-modified cell therapy, and cell therapy.

  • The cell therapy segment dominated the product segment in 2024. Cell therapy is the transplantation of human cells to repair or replace damaged tissue or cells. The gene-modified cell therapy segment is expected to register the fastest growth during the forecast period.

  • The oncology segment dominated the market and accounted for the largest revenue share in 2024. The rare diseases segment is expected to register the fastest CAGR during the forecast period.

  • North America dominated the cell and gene therapy bioanalytical testing services market and accounted for the largest revenue share of 41.57% in 2024. Asia Pacific cell and gene therapy bioanalytical testing services are anticipated to witness the fastest CAGR over the forecast period.

Cell And Gene Therapy Bioanalytical Testing Services Market Segmentation

Grand View Research has segmented global cell and gene therapy bioanalytical testing services market on the basis of test type, product type, stage of development by product type, indication and region:

Cell & Gene Therapy Bioanalytical Testing Services Test Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Bioavailability & Cell & Gene Therapy Bioanalytical Testing Services

  • Pharmacokinetics

  • Pharmacodynamics

  • Other Test Type

Cell & Gene Therapy Bioanalytical Testing Services Product Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Gene Therapy

    • Ex-vivo

    • In-vivo

  • Gene-Modified Cell Therapy

    • CAR T-cell therapies

    • CAR-NK cell therapy

    • TCR-T cell therapy

    • Other

  • Cell Therapy

Cell & Gene Therapy Bioanalytical Testing Services Stage of Development by Product Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Non-Clinical

    • Gene Therapy

    • Gene-Modified Cell Therapy

    • Cell Therapy

  • Clinical

    • Gene Therapy

    • Gene-Modified Cell Therapy

    • Cell Therapy

Cell & Gene Therapy Bioanalytical Testing Services Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Oncology

  • Infectious Diseases

  • Neurological disorders

  • Rare Diseases

  • Others

Cell & Gene Therapy Bioanalytical Testing Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players in the Cell & Gene Therapy Bioanalytical Testing Services Market

  • BioAgilytix Labs

  • KCAS Bioanalytical Services

  • IQVIA, Inc.

  • Laboratory Corporation of America Holdings

  • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)

  • Prolytix

  • Pharmaron

  • Charles River Laboratories

  • Syneos Health

  • SGS SA

  • Intertek Group Plc

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization